Further scandal for China’s pharmaceutical industry
Chinese police say they have opened an investigation into reports that at least 145 children received an expired polio vaccine...
List view / Grid view
Chinese police say they have opened an investigation into reports that at least 145 children received an expired polio vaccine...
Nanoparticles could offer a new way to help eradicate the disease worldwide...
New research could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking...
Researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: Extended relief from peanut allergies...
Engineers have developed a miniature, ultra-low power injectable biosensor that could be used for continuous, long-term alcohol monitoring...
Researchers have used kappa-carrageenan and nanosilicates to form injectable hydrogels to promote haemostasis and facilitate wound healing...
Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the NIAID...
Medical researchers point to a promising route for designing an effective vaccine for the respiratory syncytial virus...
NIAID officials detail the Institute’s new strategic plan for addressing the research areas essential to creating a safe and effective universal influenza vaccine...
Study is the first 'prevention of infection' trial conducted for tuberculosis, the world's leading infectious disease killer...
New injectable delivery system can slowly release drug carriers for months...
Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested...
Results from two Phase 1 clinical trials show an experimental Zika vaccine is safe and induces an immune response in healthy adults.
Researchers have discovered that a virus-like particle vaccine can prime the body's immune response and prevent the severe respiratory diseases...
3 March 2016 | By Emmanuel Hanon, Senior Vice President, Head of Vaccines Research & Development, GSK
Here, GSK's Emmanuel Hanon discusses maternal vaccination and how it has emerged as a promising public health strategy...